News from inmed pharmaceuticals inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.
Latest
Jan 19, 2021, 14:00 ET InMed Pharmaceuticals to Participate in 2021 Cannabinoid-Derived Pharmaceuticals Industry Review Summit Europe
InMed's Michael Woudenberg, Karen Long & Prof. Mauro Maccarrone among Expert Speakers VANCOUVER, BC, Jan. 19, 2021 /PRNewswire/ - InMed...
Jan 08, 2021, 07:30 ET InMed Announces Results of Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
TSX: IN NASDAQ: INM VANCOUVER, BC, Jan. 8, 2021 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a...
Jan 05, 2021, 16:52 ET InMed to Participate at Virtual Conferences in January 2021
VANCOUVER, BC, Jan. 5, 2021 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage...
Dec 03, 2020, 07:30 ET InMed Licenses MiDROPS® Delivery Technology from EyeCRO for the Delivery of Therapeutic Cannabinoids
TSX:IN NASDAQ:INM - Initial application with INM-088 to treat ocular disease - VANCOUVER, BC, Dec. 3, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc....
Nov 25, 2020, 07:30 ET InMed Announces Results of Initial Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
VANCOUVER, BC, Nov. 25, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage...
Nov 24, 2020, 20:00 ET InMed Announces Election of Directors
VANCOUVER, BC, Nov. 24, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ:INM) (TSX:IN), a clinical-stage...
Nov 18, 2020, 07:30 ET InMed Pharmaceuticals and BayMedica Announce Collaboration for Manufacturing and Testing of Novel Cannabinoid Therapeutics
VANCOUVER, BC, Nov. 18, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ:INM) (TSX:IN), a clinical-stage...
Nov 16, 2020, 11:42 ET InMed Pharmaceuticals Announces the Closing of US$8 Million Public Offering
VANCOUVER, BC, Nov. 16, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage...
Nov 13, 2020, 07:30 ET InMed Pharmaceuticals Reports First Quarter Fiscal 2021 IFRS Financial Results
VANCOUVER, BC, Nov. 13, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage...
Nov 12, 2020, 09:10 ET InMed Announces Pricing of US$8M Public Offering and Listing on the Nasdaq Capital Market Under the Symbol "INM"
VANCOUVER, BC, Nov. 12, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (NASDAQ: INM) (TSX: IN), a clinical-stage...
Nov 05, 2020, 18:21 ET InMed Reschedules Reporting of First Quarter Financial Results and Business Update to November 13, 2020
VANCOUVER, BC, Nov. 5, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical-stage...
Nov 04, 2020, 07:30 ET InMed Pharmaceuticals to Report First Quarter Fiscal 2021 Financial Results and Business Update on November 6, 2020
TSX:IN OTCQX:IMLFF VANCOUVER, BC, Nov. 4, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a...
Sep 24, 2020, 07:30 ET InMed Announces Completion of Subject Treatments in Second Phase 1 Clinical Trial of INM-755 CBN Cream in Healthy Subjects
VANCOUVER, BC, Sept. 24, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical-stage...
Sep 22, 2020, 07:30 ET InMed Pharmaceuticals Announces Additional IntegraSyn™ Patent Filing
TSX:IN OTCQX:IMLFF VANCOUVER, BC, Sept. 22, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN) (OTCQX:IMLFF), a...
Sep 08, 2020, 07:30 ET InMed Pharmaceuticals Reports Full Year Fiscal 2020 Financial Results and Provides Business Update
VANCOUVER, BC, Sept. 8, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical-stage...
Sep 02, 2020, 07:30 ET InMed Pharmaceuticals to Report Full Year Fiscal 2020 Financial Results and Business Update on September 8, 2020
TSX:IN OTCQX:IMLFF VANCOUVER, BC, Sept. 2, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a...
Jul 07, 2020, 07:30 ET InMed Announces Dosing Initiation in 2nd Phase 1 trial with INM-755
TSX:IN OTCQX:IMLFF VANCOUVER, BC, July 7, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a...
Jun 30, 2020, 18:18 ET InMed Announces Completion of Share Consolidation
Trading of Consolidated Shares on TSX Expected to Begin on July 3rd, 2020 VANCOUVER, BC, June 30, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc....
Jun 24, 2020, 07:30 ET InMed Introduces IntegraSyn™: An Integrated Cannabinoid Manufacturing System
VANCOUVER, BC, June 24, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical-stage...
Jun 19, 2020, 18:20 ET InMed Announces Filing of Registration Statement in Connection with United States Offering, Application to Seek Nasdaq Listing and Planned Share Consolidation
VANCOUVER, BC, June 19, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN) (OTCQX: IMLFF), a clinical-stage...
May 27, 2020, 07:30 ET InMed Releases CBN Preclinical Results in Glaucoma
VANCOUVER, May 27, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical...
May 19, 2020, 07:30 ET InMed Pharmaceuticals Continues to Strengthen Biosynthesis Patent Family
VANCOUVER, May 19, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical...
May 14, 2020, 07:30 ET InMed Pharmaceuticals Reports Third Quarter Fiscal 2020 Financial Results and Provides R&D and Business Update
VANCOUVER, May 14, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX: IN; OTCQX: IMLFF), a clinical-stage pharmaceutical ...
May 12, 2020, 07:30 ET InMed Files PCT Patent Application for Neuroprotection in Glaucoma
VANCOUVER, May 12, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical-stage pharmaceutical...
May 08, 2020, 07:30 ET InMed Pharmaceuticals to Report Third Quarter Fiscal 2020 Financial Results and Business Update on May 14, 2020
VANCOUVER, May 8, 2020 /PRNewswire/ - InMed Pharmaceuticals Inc. ("InMed" or the "Company") (TSX:IN; OTCQX:IMLFF), a clinical stage pharmaceutical...
